Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevanac for Macular Edema Prevention in Diabetic Retinopathy
NCT00939276Phase 3Terminated
- Sponsor
- Alcon Inc.
- Start
- Aug 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nepafenac in macular edema, sponsored by Alcon Inc.. Started Aug 2009; status: terminated.
02
Drugs
nepafenac
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00939276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939276.